Literature DB >> 17240142

Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor.

Stephen C McKeown1, David F Corbett, Aaron S Goetz, Thomas R Littleton, Eric Bigham, Celia P Briscoe, Andrew J Peat, Steve P Watson, Deirdre M B Hickey.   

Abstract

The discovery, synthesis and structure-activity relationship (SAR) of novel carboxylic acid agonists for GPR40 are described. Aryl propionic acid 1, identified from a high throughput screen, was selected for chemical exploration. Compound 2 was identified as our lead molecule through efficient solid phase combinatorial array chemistry and had an attractive in vitro and in vivo pharmacokinetic profile in rat. These ligands may prove useful in establishing a role for GPR40 in insulin regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17240142     DOI: 10.1016/j.bmcl.2006.12.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  G protein-coupled receptors and insulin secretion: 119 and counting.

Authors:  S R Murthy Madiraju; Vincent Poitout
Journal:  Endocrinology       Date:  2007-06       Impact factor: 4.736

Review 2.  Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects.

Authors:  Stefano Costanzi; Susanne Neumann; Marvin C Gershengorn
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

3.  Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist.

Authors:  Rieko Takano; Masao Yoshida; Masahiro Inoue; Takeshi Honda; Ryutaro Nakashima; Koji Matsumoto; Tatsuya Yano; Tsuneaki Ogata; Nobuaki Watanabe; Masakazu Hirouchi; Tomoko Yoneyama; Shuichiro Ito; Narihiro Toda
Journal:  ACS Med Chem Lett       Date:  2015-01-13       Impact factor: 4.345

4.  Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.

Authors:  Elisabeth Christiansen; Maria E Due-Hansen; Christian Urban; Nicole Merten; Michael Pfleiderer; Kasper K Karlsen; Sanne S Rasmussen; Mette Steensgaard; Alexandra Hamacher; Johannes Schmidt; Christel Drewke; Rasmus Koefoed Petersen; Karsten Kristiansen; Susanne Ullrich; Evi Kostenis; Matthias U Kassack; Trond Ulven
Journal:  ACS Med Chem Lett       Date:  2010-07-02       Impact factor: 4.345

5.  Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles.

Authors:  Yingcai Wang; Jiwen Jim Liu; Paul J Dransfield; Liusheng Zhu; Zhongyu Wang; Xiaohui Du; Xianyun Jiao; Yongli Su; An-Rong Li; Sean P Brown; Annie Kasparian; Marc Vimolratana; Ming Yu; Vatee Pattaropong; Jonathan B Houze; Gayathri Swaminath; Thanhvien Tran; Khanh Nguyen; Qi Guo; Jane Zhang; Run Zhuang; Frank Li; Lynn Miao; Michael D Bartberger; Tiffany L Correll; David Chow; Simon Wong; Jian Luo; Daniel C-H Lin; Julio C Medina
Journal:  ACS Med Chem Lett       Date:  2013-05-07       Impact factor: 4.345

Review 6.  Lipid receptors and islet function: therapeutic implications?

Authors:  M A Kebede; T Alquier; M G Latour; V Poitout
Journal:  Diabetes Obes Metab       Date:  2009-11       Impact factor: 6.577

Review 7.  Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetes.

Authors:  Charles F Burant
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.